 "HealthCare Global's Rs 650-cr IPO subscribed 54% on Day 2")
The initial public offering (IPO) of cancer-care network operator HealthCare Global Enterprises (HCG) was subscribed 54 per cent on the second day of the offer on Thursday.
The Rs 650-crore issue received bids for 88,13,610 shares against the total issue size of 1,63,90,000 shares, the National Stock Exchange's data showed.
The qualified institutional buyers' portion was subscribed 75 per cent, while retail investors segment saw 31 per cent subscription.
HCG is the fourth company after Precision Camshafts, TeamLease Services and Quick Heal Technologies to hit Dalal Street with an IPO in 2016. It has already raised Rs 292 crore through issue of shares to 11 anchor investors. The company has fixed the price band at Rs 205-218 for the IPO which would conclude tomorrow. At the upper end of the price-band, the issue will fetch about Rs 650 crore.
The shares are proposed to be listed on BSE and National Stock Exchange (NSE).
Kotak Mahindra Capital Company, Edelweiss Financial Services, Goldman Sachs (India) Securities, IDFC Securities, IIFL Holdings and Yes Bank are the book running lead managers to the issue.
The Bengaluru-based firm operates one of the largest cancer care networks in the country under the brand name HCG.
Currently, HCG has 14 comprehensive cancer centres.
The Rs 650-crore issue received bids for 88,13,610 shares against the total issue size of 1,63,90,000 shares, the National Stock Exchange's data showed.
The qualified institutional buyers' portion was subscribed 75 per cent, while retail investors segment saw 31 per cent subscription.
Also Read
The non-institutional investors category was subscribed 27 per cent.
HCG is the fourth company after Precision Camshafts, TeamLease Services and Quick Heal Technologies to hit Dalal Street with an IPO in 2016. It has already raised Rs 292 crore through issue of shares to 11 anchor investors. The company has fixed the price band at Rs 205-218 for the IPO which would conclude tomorrow. At the upper end of the price-band, the issue will fetch about Rs 650 crore.
The shares are proposed to be listed on BSE and National Stock Exchange (NSE).
Kotak Mahindra Capital Company, Edelweiss Financial Services, Goldman Sachs (India) Securities, IDFC Securities, IIFL Holdings and Yes Bank are the book running lead managers to the issue.
The Bengaluru-based firm operates one of the largest cancer care networks in the country under the brand name HCG.
Currently, HCG has 14 comprehensive cancer centres.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%